Article
Pharmacogenetics of Erectile Dysfunction: Navigating into Uncharted Waters
1 Aug 2014
Abstract excerpt
Sildenafil and other PDE-5 inhibitors have revolutionized erectile dysfunction (ED) treatment. However, a significant number of patients do not respond or present adverse reactions to these drugs. While genetic polymorphisms may underlie this phenomenon, very little research has been undertaken in this research field. Most of the current knowledge is based on sildenafil, thus almost completely ignoring other...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
